Grifols reported EUR1.77B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 428K Sep/2025
aTyr Pharma USD 26.94M 6.63M Sep/2025
GlaxoSmithKline GBP 5.76B 203M Sep/2025
Grifols EUR 1.77B 22.04M Sep/2025